Cargando…
Hemolytic anemia in COVID-19
COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with angiotensin-converting enzyme 2 (ACE2) receptor, CD147, and erythrocyte Band3 protein. Hemolytic anemia has been linked to COVID-19 th...
Autores principales: | Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Kaushik, Ajeet, Kujawska, Małgorzata, Batiha, Gaber El-Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263052/ https://www.ncbi.nlm.nih.gov/pubmed/35802164 http://dx.doi.org/10.1007/s00277-022-04907-7 |
Ejemplares similares
-
Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Potential role of lipoxin in the management of COVID-19: a narrative review
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022) -
Nitazoxanide and COVID-19: A review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
COVID-19 and corticosteroids: a narrative review
por: El-Saber Batiha, Gaber, et al.
Publicado: (2022) -
The possible role of ursolic acid in Covid-19: A real game changer
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)